143 related articles for article (PubMed ID: 9554589)
21. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
22. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.
Urayama S; Kawakami A; Nakashima T; Tsuboi M; Yamasaki S; Hida A; Ichinose Y; Nakamura H; Ejima E; Aoyagi T; Nakamura T; Migita K; Kawabe Y; Eguchi K
J Lab Clin Med; 2000 Sep; 136(3):181-93. PubMed ID: 10985496
[TBL] [Abstract][Full Text] [Related]
23. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.
Kataoka S; Naito M; Tomida A; Tsuruo T
Exp Cell Res; 1994 Nov; 215(1):199-205. PubMed ID: 7957669
[TBL] [Abstract][Full Text] [Related]
24. Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis.
Mashima T; Udagawa S; Tsuruo T
J Cell Physiol; 2001 Sep; 188(3):352-8. PubMed ID: 11473362
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
26. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
[TBL] [Abstract][Full Text] [Related]
27. Bcl-2 inhibitors potentiate the cytotoxic effects of radiation in Bcl-2 overexpressing radioresistant tumor cells.
Hara T; Omura-Minamisawa M; Chao C; Nakagami Y; Ito M; Inoue T
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):517-28. PubMed ID: 15667975
[TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
29. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells.
Yin DX; Schimke RT
Cancer Res; 1995 Nov; 55(21):4922-8. PubMed ID: 7585531
[TBL] [Abstract][Full Text] [Related]
30. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
Giuliano M; Lauricella M; Vassallo E; Carabillò M; Vento R; Tesoriere G
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1300-11. PubMed ID: 9660477
[TBL] [Abstract][Full Text] [Related]
32. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism.
Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S
Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331
[TBL] [Abstract][Full Text] [Related]
33. The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide.
Bardeleben RV; Dunkern T; Kaina B; Fritz G
Int J Mol Med; 2002 Oct; 10(4):473-9. PubMed ID: 12239596
[TBL] [Abstract][Full Text] [Related]
34. Bcl-2 gene silencing in pediatric epithelial liver tumors.
Warmann SW; Frank H; Heitmann H; Ruck P; Herberts T; Seitz G; Fuchs J
J Surg Res; 2008 Jan; 144(1):43-8. PubMed ID: 17574594
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.
Scheltema JM; Romijn JC; van Steenbrugge GJ; Schröder FH; Mickisch GH
Anticancer Res; 2001; 21(5):3161-6. PubMed ID: 11848468
[TBL] [Abstract][Full Text] [Related]
36. Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure.
Wongvaranon P; Pongrakhananon V; Chunhacha P; Chanvorachote P
Anticancer Res; 2013 Dec; 33(12):5433-44. PubMed ID: 24324079
[TBL] [Abstract][Full Text] [Related]
37. An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.
Vrana JA; Bieszczad CK; Cleaveland ES; Ma Y; Park JP; Mohandas TK; Craig RW
Cancer Res; 2002 Feb; 62(3):892-900. PubMed ID: 11830549
[TBL] [Abstract][Full Text] [Related]
38. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
Luo D; Cheng SC; Xie H; Xie Y
Biochem Cell Biol; 2000; 78(2):119-26. PubMed ID: 10874473
[TBL] [Abstract][Full Text] [Related]
39. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
Ritke MK; Rusnak JM; Lazo JS; Allan WP; Dive C; Heer S; Yalowich JC
Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Schmelz K; Wieder T; Tamm I; Müller A; Essmann F; Geilen CC; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2004 Sep; 23(40):6743-59. PubMed ID: 15273737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
